June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Paolo Tarantino: We need Biomarkers to Tailor Treatment with T-DXd
Jun 3, 2025, 10:50

Paolo Tarantino: We need Biomarkers to Tailor Treatment with T-DXd

Paolo Tarantino, Advanced Research Fellow at Dana-Farber Cancer Institute and Harvard Medical School, reshared a post by Dana-Farber’s Breast Oncology Center, on X:

Dr. Isaacs made it clear in her DB09 discussion: we need biomarkers to tailor treatment with T-DXd!

At Dana-Farber’s Breast Oncology Center, we’re committed to develop them.

With the help of terrific partners, we tested HER2DX & RPPA in a pilot of 40 pts.

Intriguing results, working on validation.”

Quoting Dana-Farber’s Breast Oncology Center‘s post:

Metastatic Breast Cancer Poster Session:

Quantitative pre-treatment assessment of trastuzumab deruxtecan (TDXd) antibody target (HER2) and payload target (topoisomerase 1, Topo1) to predict outcomes in Metastatic Breast Cancer (MBC).

Abstract 1032 | Poster Bd 11 | Jun 2, 9-12 PM CDT | Hall A.”

Paolo Tarantino: We need Biomarkers to Tailor Treatment with T-DXd

More posts featuring Paolo Tarantino.